Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.
2 reports, 1 independent
Updated Sep 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Smith & Nephew
a company producing medical equipment
Nothing else this week.
Related events
- Morgan Stanley and Royal Bank of Canada initiated coverage of Csquare stock on August 10, 2026, setting ratings of overweight and outperform, respectively.
- Morgan Stanley reaffirmed an underweight rating and Citigroup restated a sell rating on Handelsbanken, reported by MarketBeat.
- Morgan Stanley upgraded Cboe Global Markets to an overweight rating on October 9, 2026.
- Morgan Stanley reaffirmed an overweight rating on STMicroelectronics, and Eastern Bank raised its position in the shares.
- Multiple financial firms (Barclays, UBS, Morgan Stanley, Jefferies) issued rating and price target updates for Equity Lifestyle Properties.